Related Experiment Video
Updated: May 18, 2026

Mouse Model for Pancreas Transplantation Using a Modified Cuff Technique
Published on: December 16, 2017
Post-transplantation diabetes mellitus.
1Nephrology-Dialysis-Renal Transplantation Unit, Ibn Sina Hospital, Rabat, Morocco. zbitinajoua@live.fr
Post-kidney transplantation diabetes (PTDM) affects 15.2% of patients, with advanced age and high-dose immunosuppressants like steroids and cyclosporine being key risk factors. Aggressive management is crucial for this significant patient group.
Area of Science:
- Nephrology
- Endocrinology
- Immunology
Background:
- Kidney transplantation is a life-saving procedure.
- Immunosuppressive therapy is essential to prevent graft rejection.
- Post-transplant complications, including diabetes, can impact long-term outcomes.
Purpose of the Study:
- To determine the prevalence of post-kidney transplantation diabetes (PTDM).
- To identify risk factors associated with PTDM development.
- To outline management strategies for PTDM.
Main Methods:
- Retrospective study of 92 non-diabetic kidney transplant recipients.
- Data collection on patient demographics, immunosuppressive drug regimens, and diabetes diagnosis.
- Diabetes defined by WHO and American Diabetes Association criteria.
Main Results:
- The prevalence of PTDM was 15.2% in the study population.
- Significant risk factors for PTDM included advanced age, high-dose steroids, and cyclosporine.
- Management involved diet modification, oral anti-diabetic agents, and insulin therapy.
Conclusions:
- PTDM is a significant complication in kidney transplant recipients.
- Advanced age and specific immunosuppressive drugs are key risk factors.
- Effective management requires a multifaceted approach.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Diabetic Nephropathy
Diabetic Retinopathy
Diabetes Mellitus: Type 2 and Gestational

